Most people are willing to invest in their health — but investing in healthcare stocks is a different story.
As investors, we look for businesses built on stability, not speculation.
While Wall Street chases the next “revolutionary” biotech with 100x potential, the reality is often a coin toss.
We’re more interested in a steady, overlooked healthcare company quietly building vertical integration — the kind of progress that doesn’t vanish overnight.
📈The Stock: Al-Dawaa (4163.SR)
Al-Dawaa operates over 900 physical pharmacies and has steadily expanded into multiple layers of the healthcare industry
Healthcare Logistics → Built Proceed, a logistics arm powering nationwide distribution
Medical Device Manufacturing → Owns PREMI for healthcare equipment
Public Sector Fulfillment → 70% of all prescriptions in Saudi Arabia
This is a deeply entrenched, high-retention business—not just selling products, but playing a central role in the country’s healthcare infrastructure.
And with its logistics capabilities, Al-Dawaa gains a defensible moat most retailers can’t match.
In Short: The country needs them to be healthy
💰Show me The Money
Metric | 2022 | 2023 | 2024 |
Profit Margin (%) | 5.73 | 5.74 | 5.74 |
Debt To Equity | 3.11 | 2.59 | 2.46 |
Return On Equity(%) | 30.06 | 28.19 | 26.09 |
Ownership also comes with a 3.22% dividend yield — a rare bonus in a growing healthcare business.
With improving financials and a strong foundation already in place, management now has the flexibility to deploy excess cash strategically, including reducing the debt-to-equity ratio and strengthening the balance sheet further.
See You Next Sunday!